Blackstone Inc’s Guardant Health GH Stock Holding History

Blackstone Inc’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-169,750	Closed	-$21.1M	–	641
2021 Q2	$21.1M	Buy	+169,750	New	+$22.8M	0.05%	100

Other funds holding GH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Blackstone Inc's GH Position: Q3 2021 in Review

Blackstone Inc sold out of Guardant Health (GH) in Q3 2021, closing a stake of 169,750 shares — an estimated $21.1M sold.

Blackstone Inc first reported a position in GH in Q2 2021 and held it in 1 quarter. The position peaked at $21.1M in Q2 2021. 374 funds tracked by Wall St. Rank hold GH as of Q3 2021.

Blackstone Inc reported no remaining Guardant Health position as of Q3 2021 after selling out during the quarter.
Blackstone Inc sold 169,750 Guardant Health shares in Q3 2021, an estimated $21.1M.
Blackstone Inc first reported a position in Guardant Health in Q2 2021 and held it in 1 quarter.
Blackstone Inc's Guardant Health position peaked at $21.1M in Q2 2021.
374 funds tracked by Wall St. Rank held Guardant Health as of Q3 2021.

Based on Blackstone Inc's 13F filing for Q3 2021, filed 16 Nov 2021.